Insulet Corp. is a healthcare company based in the United States that offers innovative solutions for diabetes management. Their flagship product, the Omnipod system, makes continuous subcutaneous insulin infusion therapy easier and more convenient. With over 425,000 users worldwide, Insulet Corp. has established itself as a leader in the industry. The company has a medium ESG risk rating score of 21.5, showcasing their commitment to sustainability and good governance practices.